S1P Therapeutics
Blacksburg, US · Founded 2019 · Delaware corporation
Biotech
Founders & leadership
KL
Kevin LynchExecutive Officer, Director
WS
Webster SantosExecutive Officer, Director
RS
Ronald SaycoExecutive Officer, Director
Reported raises · per SEC filings
Form D private placements▶$2MraisedJun 2023 · 1 investors · PharmaceuticalsRule 506(b)
Officers, directors & promoters on the filing
- Kevin LynchExecutive Officer, Director
- Webster SantosExecutive Officer, Director
- Ronald SaycoExecutive Officer, Director
- Offering amount
- $3M
- Amount sold
- $2M
- First sale
- May 2023
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.